Vascular Biogenics Ltd (VBLT) stock has fallen -44.92% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives VBLT stock a score of 31 out of a possible 100. That rank is primarily influenced by a short-term technical score of 8. VBLT's rank also includes a long-term technical score of 15. The fundamental score for VBLT is 70. In addition to the average rating from Wall Street analysts, VBLT stock has a mean target price of $5.88. This means analysts expect the stock to add 316.67% over the next 12 months.
Vascular Biogenics Ltd (VBLT) Stock Decreases -14.02% This Week; Should You Buy?
VBLT has an Overall Score of 31. Find out what this means to you and get the rest of the rankings on VBLT!